CH569691A5 - - Google Patents

Info

Publication number
CH569691A5
CH569691A5 CH517473A CH517473A CH569691A5 CH 569691 A5 CH569691 A5 CH 569691A5 CH 517473 A CH517473 A CH 517473A CH 517473 A CH517473 A CH 517473A CH 569691 A5 CH569691 A5 CH 569691A5
Authority
CH
Switzerland
Application number
CH517473A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH569691(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH569691A5 publication Critical patent/CH569691A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH517473A 1972-04-12 1973-04-11 CH569691A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
CH569691A5 true CH569691A5 (en:Method) 1975-11-28

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
CH517473A CH569691A5 (en:Method) 1972-04-12 1973-04-11
CH1112475A CH580563A5 (en:Method) 1972-04-12 1973-04-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1112475A CH580563A5 (en:Method) 1972-04-12 1973-04-11

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en:Method)
KR (1) KR790000113B1 (en:Method)
AR (1) AR203822A1 (en:Method)
AT (1) AT323719B (en:Method)
AU (1) AU472734B2 (en:Method)
BE (1) BE798051A (en:Method)
BG (1) BG23001A3 (en:Method)
CA (1) CA1018188A (en:Method)
CH (2) CH569691A5 (en:Method)
CS (2) CS190448B2 (en:Method)
CY (1) CY963A (en:Method)
DD (1) DD107670B3 (en:Method)
DE (1) DE2317710C2 (en:Method)
DK (1) DK142750C (en:Method)
ES (1) ES413639A1 (en:Method)
FR (1) FR2182947B1 (en:Method)
GB (1) GB1392674A (en:Method)
HK (1) HK50178A (en:Method)
HU (2) HU167597B (en:Method)
IE (1) IE37511B1 (en:Method)
IL (1) IL42016A (en:Method)
KE (1) KE2870A (en:Method)
MY (1) MY7800381A (en:Method)
NL (1) NL174459C (en:Method)
PH (1) PH11041A (en:Method)
PL (2) PL90695B1 (en:Method)
RO (2) RO70892A (en:Method)
SE (1) SE399064B (en:Method)
SU (1) SU496719A3 (en:Method)
YU (2) YU36483B (en:Method)
ZA (1) ZA732136B (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en:Method) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (en:Method) * 1989-12-18 1991-08-23
WO1992020645A1 (fr) * 1991-05-20 1992-11-26 Tsumura & Co. Analogues de phellodendrine et suppresseur d'allergie de type iv les contenant en tant qu'ingredients actifs
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
WO2005092305A2 (en) 2004-03-26 2005-10-06 New Era Biotech Ltd Compounds for treating aids and other diseases
AU2003274605A1 (en) 2002-10-03 2004-04-23 Novaremed Ltd Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
BR112012002246A2 (pt) 2009-07-31 2019-09-24 Cognition Therapeutics Inc composto, composto ou sal farmaceutico aceitavel deste, composição farmaceutica, metodo para inibir, tratar e/ou reduzir o declinio cognitivol e/ou doença de akzhmer em um paciente
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
HK1202248A1 (en) * 2011-08-25 2015-09-25 考格尼申治疗股份有限公司 Compositions and methods for treating neurodegenerative disease
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
MX388366B (es) 2017-05-15 2025-03-19 Cognition Therapeutics Inc Composiciones para tratar enfermedades neurodegenerativas.
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
AU472734B2 (en) 1976-06-03
DK142750C (da) 1981-08-17
YU97673A (en) 1982-02-25
BE798051A (fr) 1973-10-11
AU5438573A (en) 1974-10-17
PL90695B1 (en:Method) 1977-01-31
BG23001A3 (bg) 1977-05-20
AR203822A1 (es) 1975-10-31
ZA732136B (en) 1974-03-27
HU166213B (en:Method) 1975-02-28
CS190406B2 (en) 1979-05-31
KR790000113B1 (en) 1979-03-20
RO70892A (ro) 1982-02-26
NL7305097A (en:Method) 1973-10-16
YU36483B (en) 1984-02-29
DK142750B (da) 1981-01-12
YU321279A (en) 1983-04-27
PH11041A (en) 1977-10-25
JPS497237A (en:Method) 1974-01-22
ES413639A1 (es) 1976-01-16
KE2870A (en) 1978-09-01
DE2317710C2 (de) 1983-08-04
YU37113B (en) 1984-08-31
IE37511B1 (en) 1977-08-03
HU167597B (en:Method) 1975-11-28
GB1392674A (en) 1975-04-30
JPS5825656B2 (ja) 1983-05-28
IL42016A (en) 1976-05-31
AT323719B (de) 1975-07-25
CH580563A5 (en:Method) 1976-10-15
DE2317710A1 (de) 1973-10-18
JPS58131945A (ja) 1983-08-06
SU496719A3 (ru) 1975-12-25
FR2182947B1 (en:Method) 1976-07-02
JPS6221343B2 (en:Method) 1987-05-12
CS190448B2 (en) 1979-05-31
DD107670A5 (de) 1974-08-12
HK50178A (en) 1978-09-15
CY963A (en) 1978-12-22
NL174459B (nl) 1984-01-16
NL174459C (nl) 1984-06-18
RO65105A (ro) 1980-01-15
SE399064B (sv) 1978-01-30
IL42016A0 (en) 1973-06-29
CA1018188A (en) 1977-09-27
DD107670B3 (de) 1988-04-06
PL94207B1 (en:Method) 1977-07-30
FR2182947A1 (en:Method) 1973-12-14
MY7800381A (en) 1978-12-31

Similar Documents

Publication Publication Date Title
FR2182947B1 (en:Method)
FR2214147A1 (en:Method)
FR2168134B2 (en:Method)
JPS4995117U (en:Method)
JPS4886023A (en:Method)
JPS4891661U (en:Method)
JPS491054U (en:Method)
JPS4960890U (en:Method)
JPS49105152U (en:Method)
CH572247A5 (en:Method)
CH569819A5 (en:Method)
CH571098B5 (en:Method)
CH577786A5 (en:Method)
CH572336A5 (en:Method)
CH573830A5 (en:Method)
CH574582A5 (en:Method)
CH570389A5 (en:Method)
CH575066A5 (en:Method)
CH575469A5 (en:Method)
CH576845A5 (en:Method)
CH577009A5 (en:Method)
CH570331A5 (en:Method)
CH561760A5 (en:Method)
CH561843A5 (en:Method)
CH586709A5 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased